Over the past three months, Catabasis Pharmaceuticals Inc. [CATB] ended the trading day at $1.35 and exhibited a change of -1.10% with a 24 hour trading and reached upto the volume of 1.15M compared to its recorded trading volume of 0.83 million. CATB generated a 1 year amount change with -72.64%. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by -4.90% with an amount shift of -76.79% over the last month.

On 12, November 2020, Catabasis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides a Corporate Update. According to news published on Yahoo Finance, — Cash and Cash Equivalents Totaled $52.9 Million as of September 30, 2020 –.

Analyst Birdseye View:

The most recent analyst activity for Catabasis Pharmaceuticals Inc. [NASDAQ:CATB] stock was on October 27, 2020, when it was Downgrade with a Perform rating from Oppenheimer. On October 27, 2020, H.C. Wainwright Downgrade a Neutral rating. On October 01, 2020, H.C. Wainwright Initiated a Buy rating and increased its price target to $24. On October 05, 2017, Oppenheimer Reiterated an Outperform rating and increased its price target to $7. On February 02, 2017, Citigroup Downgrade a Neutral rating. On December 22, 2016, H.C. Wainwright Initiated a Buy rating and boosted its target amount on this stock to $14. Wedbush elevated its amount target by recapitulating a higher weight for this stock.

In the past 52 weeks of trading, this stock has oscillated between a low of $1.25 and a peak of $8.59. Right now, according to Wall Street analyst the average 12-month amount target is $17.75. At the most recent market close, shares of Catabasis Pharmaceuticals Inc. [NASDAQ:CATB] were valued at $1.35.

FUNDAMENTAL ANALYSIS

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 5.93 and the whole liability to whole assets at 5.39. It shows enduring liability to the whole principal at 2.71 and enduring liability to assets at 0.02 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 1.3333 points at 1st support level, the second support level is making up to 1.3067. But as of 1st resistance point, this stock is sitting at 1.4033 and at 1.4467 for 2nd resistance point.

Catabasis Pharmaceuticals Inc. [CATB] reported its earnings at -$0.56 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.51/share signifying the difference of -0.05 and -9.80% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.53 calling estimates for -$0.45/share with the difference of -0.08 depicting the surprise of -17.80%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Catabasis Pharmaceuticals Inc. [NASDAQ:CATB] is 8.00. Likewise, the Quick ratio is also the same, showing Cash ratio at 7.20. Now if looking for a valuation of this stock’s amount to book ratio is 2.06.